针对帕金森病使用数字技术的个性化医疗方法
Amit Khanna1, Graham Jones2,3
1Neuroscience Global Drug Development, Novartis Pharma AG, Basel, Switzerland.
JMIR formative research
|September 27, 2023
概括
帕金森病 (PD) 呈现出多样化的患者表型,需要个性化的P4医学 (预测,预防,个性化,参与) 方法,以进行量身定制的干预和改善这种神经退行性疾病的管理.
科学领域:
- 神经退行性疾病 神经退行性疾病
- 个性化医疗是个性化的医疗.
- P4 医学 医学
背景情况:
- 帕金森病 (PD) 影响全球超过1000万,导致严重的运动和认知障碍,并带来巨大的经济负担.
- 不同的患者表型表现出不同的症状,药物反应和疾病进展,使治疗策略复杂化.
- 长期的PD前兆期为早期,个性化的干预提供了一个窗口.
研究的目的:
- 探索个性化的方法来治疗帕金森病的症状管理和疾病控制.
- 突出将P4医学原则 (预测,预防,个性化,参与) 应用于PD的机会.
- 为量身定制的干预措施引入复合直角患者监测的概念.
主要方法:
- 审查目前对PD异质性和治疗挑战的理解.
- 整合新兴诊断和监测策略的概念框架.
- 利用观察性患者队列来改进干预方法.
主要成果:
- 鉴定了基于不同患者表型的个性化干预的机会.
- 建议P4药物作为定制诊断和监测策略的框架.
- 强调了复合直角患者监测对个性化护理的潜力.
结论:
- 个性化的P4医学方法,包括复合直角监测,有望优化帕金森病的管理.
- 量身定制的干预措施可能会延迟疾病的发病和进展,受氧化压力等因素的影响.
- 这些策略也可能为相关的神经退行性疾病 (如阿尔茨海默氏症和亨廷顿病) 的治疗开发提供信息.
相关概念视频
Parkinson's Disease: Treatment
292
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
292
Parkinson's Disease: Overview
590
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
590
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Issues And Trends In Healthcare Delivery System
5.7K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.7K


